Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

30

Revenue 2017

Botox/Neuromodulator

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Botox/Neuromodulator was produced by Allergan.

ABPI reprimands for four pharma firms

ABPI reprimands for four pharma firms Publicly reprimanded by the Prescription Medicines Code of Practice Authority, Allergan successively failed to comply with an undertaking, continuing to claim that Vistabel/Botox was clinically more potent than Bocouture/Xeomin.

Hospira CEO joins board of Kythera

Hospira CEO joins board of Kythera He joined the company following a 16-year stint at Botox developers Allergan, serving as president from 2006. ... This experience in aesthetic products such as Botox will serve him well in his role at Kythera, with the company currently developing

Valeant to slash workforce after Bausch + Lomb takeover

Valeant to slash workforce after Bausch + Lomb takeover Last year it snapped up skincare company Medicis in a $2.6bn deal that added Botox rival Dysport (abobotulinumtoxin A) to its portfolio along with a range of wrinkle treatments, and

Ipsen strengthens neurology efforts with Syntaxin purchase

Ipsen strengthens neurology efforts with Syntaxin purchase Current botulinum toxins include Ipsen's Dysport and Allergan's Botox, both of which have achieved success in cosmetic and medical procedures, but Ipsen is looking to develop the next generation

GSK staff 'confess to bribery', says China

GSK staff 'confess to bribery', says China Earlier this week, the company started an investigation into claims that sales staff gave cash incentives and other kickbacks to doctors in return for prescribing wrinkle treatment Botox (onabotulinumtoxinA).

[ Previous 5 results ] 9 10 11 12 13 14 15 16 17 18 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group, where our agencies immerse you in the world of the patient...

Latest intelligence

OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
Spotlight interview: 15 minutes on healthcare communications in gene therapy
Gavin Jones, Director of Rare Disease, OPEN Health takes 15 minutes to answer some key questions on healthcare communications in gene therapy...
How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....

Infographics